Principe et al. show that ENO1 silencing which increased integrins and uPAR (an ECM receptor), could impeded cell adhesion, invasion, and metastasis, by acting as a plasminogen receptor on the tumor cell surface in pancreatic cancer [52]. Here, ENO1 is linked to pancreatic neoplasm.